ARTICLE | Company News
Perlegen, SC Liver Research Consortium deal
February 25, 2008 8:00 AM UTC
The parties will use Perlegen's genotyping technologies to discover genetic variations that predict treatment response in samples from HCV patients treated with interferon alfa and ribavirin. Terms we...